Search

Scott David Priebe

Examiner (ID: 14721)

Most Active Art Unit
1632
Art Unit(s)
1633, 1819, 1805, 1632
Total Applications
686
Issued Applications
323
Pending Applications
150
Abandoned Applications
212

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7267214 [patent_doc_number] => 20040244064 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Transgenic flies expressing Abeta42-Flemish' [patent_app_type] => new [patent_app_number] => 10/852892 [patent_app_country] => US [patent_app_date] => 2004-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14048 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20040244064.pdf [firstpage_image] =>[orig_patent_app_number] => 10852892 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/852892
Transgenic flies expressing Abeta42-Flemish May 24, 2004 Abandoned
Array ( [id] => 7334067 [patent_doc_number] => 20040255342 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Transgenic flies expressing Abeta42-Iowa' [patent_app_type] => new [patent_app_number] => 10/852973 [patent_app_country] => US [patent_app_date] => 2004-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14058 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20040255342.pdf [firstpage_image] =>[orig_patent_app_number] => 10852973 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/852973
Transgenic flies expressing Abeta42-Iowa May 24, 2004 Abandoned
Array ( [id] => 7360148 [patent_doc_number] => 20040250302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Transgenic flies expressing Abeta42-dutch' [patent_app_type] => new [patent_app_number] => 10/853593 [patent_app_country] => US [patent_app_date] => 2004-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14066 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20040250302.pdf [firstpage_image] =>[orig_patent_app_number] => 10853593 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/853593
Transgenic flies expressing Abeta42-dutch May 24, 2004 Abandoned
Array ( [id] => 7334065 [patent_doc_number] => 20040255341 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Transgenic flies expressing Abeta42-Arctic' [patent_app_type] => new [patent_app_number] => 10/852951 [patent_app_country] => US [patent_app_date] => 2004-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13972 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20040255341.pdf [firstpage_image] =>[orig_patent_app_number] => 10852951 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/852951
Transgenic flies expressing Abeta42-Arctic May 24, 2004 Abandoned
Array ( [id] => 7457261 [patent_doc_number] => 20040197345 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Prostate derived Ets factor' [patent_app_type] => new [patent_app_number] => 10/838371 [patent_app_country] => US [patent_app_date] => 2004-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 42292 [patent_no_of_claims] => 106 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20040197345.pdf [firstpage_image] =>[orig_patent_app_number] => 10838371 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/838371
Prostate derived Ets factor May 4, 2004 Abandoned
Array ( [id] => 553508 [patent_doc_number] => 07157079 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-02 [patent_title] => 'Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms' [patent_app_type] => utility [patent_app_number] => 10/823932 [patent_app_country] => US [patent_app_date] => 2004-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 14 [patent_no_of_words] => 33325 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/157/07157079.pdf [firstpage_image] =>[orig_patent_app_number] => 10823932 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/823932
Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms Apr 12, 2004 Issued
Array ( [id] => 7402289 [patent_doc_number] => 20040175364 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-09 [patent_title] => 'Gene transfer with adenoviruses having modified fiber proteins' [patent_app_type] => new [patent_app_number] => 10/816726 [patent_app_country] => US [patent_app_date] => 2004-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15851 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20040175364.pdf [firstpage_image] =>[orig_patent_app_number] => 10816726 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/816726
Gene transfer with adenoviruses having modified fiber proteins Mar 31, 2004 Abandoned
Array ( [id] => 7103398 [patent_doc_number] => 20050106124 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'Therapeutic applications of thrombomodulin gene via viral and non-viral vectors' [patent_app_type] => utility [patent_app_number] => 10/785156 [patent_app_country] => US [patent_app_date] => 2004-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12222 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20050106124.pdf [firstpage_image] =>[orig_patent_app_number] => 10785156 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/785156
Therapeutic applications of thrombomodulin gene via viral and non-viral vectors Feb 24, 2004 Abandoned
Array ( [id] => 557628 [patent_doc_number] => 07161059 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-09 [patent_title] => 'Human hookworm model and method for maintaining human hookworm in a non-human primate' [patent_app_type] => utility [patent_app_number] => 10/780809 [patent_app_country] => US [patent_app_date] => 2004-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9773 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/161/07161059.pdf [firstpage_image] =>[orig_patent_app_number] => 10780809 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/780809
Human hookworm model and method for maintaining human hookworm in a non-human primate Feb 16, 2004 Issued
Array ( [id] => 7428864 [patent_doc_number] => 20040161848 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-19 [patent_title] => 'Adenoviral vector and related system and methods of making and use' [patent_app_type] => new [patent_app_number] => 10/778832 [patent_app_country] => US [patent_app_date] => 2004-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8682 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20040161848.pdf [firstpage_image] =>[orig_patent_app_number] => 10778832 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/778832
Adenoviral vector and related system and methods of making and use Feb 12, 2004 Abandoned
Array ( [id] => 459609 [patent_doc_number] => 07241591 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-10 [patent_title] => 'Adenovirus comprising a gene coding for glutathione peroxidase' [patent_app_type] => utility [patent_app_number] => 10/768635 [patent_app_country] => US [patent_app_date] => 2004-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4274 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/241/07241591.pdf [firstpage_image] =>[orig_patent_app_number] => 10768635 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/768635
Adenovirus comprising a gene coding for glutathione peroxidase Feb 1, 2004 Issued
Array ( [id] => 7411077 [patent_doc_number] => 20040106564 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-03 [patent_title] => 'Use of slpi for treating chronic inflammatory intestinal diseases' [patent_app_type] => new [patent_app_number] => 10/250901 [patent_app_country] => US [patent_app_date] => 2004-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11757 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20040106564.pdf [firstpage_image] =>[orig_patent_app_number] => 10250901 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/250901
Use of slpi for treating chronic inflammatory intestinal diseases Jan 4, 2004 Abandoned
Array ( [id] => 7230557 [patent_doc_number] => 20050079160 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-14 [patent_title] => 'OSR-1nucleic acids and proteins' [patent_app_type] => utility [patent_app_number] => 10/736868 [patent_app_country] => US [patent_app_date] => 2003-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 32990 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0079/20050079160.pdf [firstpage_image] =>[orig_patent_app_number] => 10736868 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/736868
OSR-1 nucleic acids and proteins Dec 15, 2003 Issued
Array ( [id] => 5767879 [patent_doc_number] => 20060019381 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Hyperthermic inducible expression vectors for gene therapy and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 10/733280 [patent_app_country] => US [patent_app_date] => 2003-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 19746 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20060019381.pdf [firstpage_image] =>[orig_patent_app_number] => 10733280 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/733280
Hyperthermic inducible expression vectors for gene therapy and methods of use thereof Dec 11, 2003 Issued
Array ( [id] => 6938534 [patent_doc_number] => 20050112097 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Method for the treatment of cancer' [patent_app_type] => utility [patent_app_number] => 10/723272 [patent_app_country] => US [patent_app_date] => 2003-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1747 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20050112097.pdf [firstpage_image] =>[orig_patent_app_number] => 10723272 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/723272
Method for the treatment of cancer Nov 25, 2003 Abandoned
Array ( [id] => 7335191 [patent_doc_number] => 20040132182 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Use of EDG2 receptor in an animal model of heart failure' [patent_app_type] => new [patent_app_number] => 10/706763 [patent_app_country] => US [patent_app_date] => 2003-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7814 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20040132182.pdf [firstpage_image] =>[orig_patent_app_number] => 10706763 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/706763
Use of EDG2 receptor in an animal model of heart failure Nov 11, 2003 Issued
Array ( [id] => 7677173 [patent_doc_number] => 20040152653 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => 'Enhanced delivery via serpin enzyme complex receptor' [patent_app_type] => new [patent_app_number] => 10/703206 [patent_app_country] => US [patent_app_date] => 2003-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3772 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 32 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20040152653.pdf [firstpage_image] =>[orig_patent_app_number] => 10703206 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/703206
Enhanced delivery via serpin enzyme complex receptor Nov 6, 2003 Abandoned
Array ( [id] => 7474889 [patent_doc_number] => 20040168209 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-26 [patent_title] => 'Novel murine polynucleotide sequences and mutant cells and mutant animals defined thereby' [patent_app_type] => new [patent_app_number] => 10/702075 [patent_app_country] => US [patent_app_date] => 2003-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 27951 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20040168209.pdf [firstpage_image] =>[orig_patent_app_number] => 10702075 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/702075
Novel murine polynucleotide sequences and mutant cells and mutant animals defined thereby Nov 3, 2003 Abandoned
Array ( [id] => 7422804 [patent_doc_number] => 20040265273 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors' [patent_app_type] => new [patent_app_number] => 10/693688 [patent_app_country] => US [patent_app_date] => 2003-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 20181 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20040265273.pdf [firstpage_image] =>[orig_patent_app_number] => 10693688 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/693688
Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors Oct 26, 2003 Abandoned
Array ( [id] => 7325048 [patent_doc_number] => 20040138115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Local pain-combating agent' [patent_app_type] => new [patent_app_number] => 10/646620 [patent_app_country] => US [patent_app_date] => 2003-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10521 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20040138115.pdf [firstpage_image] =>[orig_patent_app_number] => 10646620 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/646620
Local pain-combating agent Aug 21, 2003 Abandoned
Menu